Send us a text

Dr. S. Indu Rupassara, Ph.D., MBA is Co-Founder, President and CEO, of FruitVaccine ( http://www.fruitvaccine.org/ ), a company developing and manufacturing novel, safe and cost-effective fruit-based vaccines, with a goal of providing immunity against globally problematic infectious diseases. FruitVaccine's lead product is a vaccine which will immunize against the human respiratory syncytial virus (hRSV), a disease that all humans, especially infants and the elderly, are susceptible to, which effects the lower respiratory system and which no vaccine is available. Dr. Rupassara leads FruitVaccine overseeing its organizational, business, and R&D growth and is the Principal Investigator of FruitVaccine’s NSF-SBIR Grant Award, and has presented talks in conferences in the US, Europe, Australia, and Asia. Dr. Rupassara’s multidisciplinary expertise includes biotechnology, immunology, and ‘omics’ technologies, using an array of biological systems such as humans, animals, plants, and microorganisms. Dr. Rupassara received her PhD (Metabolomics/Biotechnology), MBA, and MS (Biochemistry) degrees from the University of Illinois at Urbana-Champaign, USA (UIUC), MSc (Microbiology) from the University of Sydney, Australia, and BSc (Agric. Sc.) from the University of Peradeniya, Sri Lanka. 

Support the show